Extended Data Table 3 Brighton collaboration case definitions for adverse maternal/fetal and neonatal outcomes of interest

From: Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial

  1. See refs. 18,19,20,21,22,23,24,25,26,27,28,29,30. WHO, World Health Organization.
Back to article page